Pat Price: key facts
- Kind of voice
- Sector leader
- Role
- Chair and Founder
- Organisation
- Radiotherapy UK
- Organisation based in
- Kensington and Bayswater
- Quoted on
- Cancer, Hospital discharge / bed-blocking
- Tracked press citations
- 3
- Most recently quoted
- 29 Sept 2026
- First quoted
- 27 Aug 2026
Who Pat Price is
Professor Pat Price is the founder and Chair of Trustees of Radiotherapy UK, the only UK national charity dedicated to improving radiotherapy treatment, and serves as Visiting Professor in the Division of Surgery and Cancer at Imperial College London. She is an academic clinical oncologist specialising in PET-based molecular imaging, advanced radiotherapy techniques, and translational research in oncology. She co-edits the standard UK oncology textbook 'Treatment of Cancer', now in its 7th edition, and served as President of the British Oncological Association from 2002 to 2004. Radiotherapy UK acts as secretariat to the All-Party Parliamentary Group on Radiotherapy, and Price regularly provides briefing to government and has given evidence to the Health and Social Care Select Committee. She is widely known for co-founding the #CatchUpWithCancer campaign, which lobbied government for a national cancer recovery plan following Covid-19-induced treatment delays, and for co-authoring a 10-point cancer control blueprint published in The Lancet Oncology and launched in Parliament in November 2023.
“thousands of patients "are going to die unnecessarily, just because the government can't get their act together to treat people on time".”
References for this biography
- 1.Our People – Radiotherapy UK — Confirms role as Chair and Visiting Professor at Imperial College London; academic background in PET imaging and radiotherapy; President of British Oncological Association 2002–2004; co-editor of Treatment of Cancer 7th edition
- 2.About – Professor Pat Price (personal website) — Confirms founder and Chair of Trustees of Radiotherapy UK; secretariat role for APPG on Radiotherapy; gives evidence to Health and Social Care Select Committee; co-founder of Global Coalition for Radiotherapy
- 3.Radiotherapy UK – Charity Commission Register — Confirms Radiotherapy UK charity registration (no. 1135902), registered address W14 8EN, and organisational contact details
- 4.The Lancet Oncology: Prof Price co-authors blueprint to tackle cancer crisis – Radiotherapy UK — Confirms co-authorship of Lancet Oncology cancer blueprint launched in Parliament, November 2023
- 5.Treatment of Cancer, 7th Edition – Routledge — Confirms Pat Price as co-editor of the standard UK oncology textbook Treatment of Cancer, 7th edition
- 6.Professor Pat Price: 'The public wants cancer to be a top priority' – Radiotherapy UK — Confirms co-founding of #CatchUpWithCancer campaign and 600,000+ petition signatures
- 7.Professor Pat Price – Short Biography (PEOPIL 2023) — Confirms 2010 return to Imperial as Visiting Professor; over 300 publications; H-factor 63; Christie Hospital Ralston Paterson Chair; Wolfson Molecular Imaging Centre
Notable achievements
- Co-authored a 10-point sustainable national cancer control blueprint published in The Lancet Oncology, launched in Parliament on 15 November 2023. Source ↗
- Founded and chairs Radiotherapy UK (charity no. 1135902), the only UK national charity devoted to radiotherapy, which acts as secretariat for the All-Party Parliamentary Group on Radiotherapy. Source ↗
- Co-founded the #CatchUpWithCancer campaign during Covid-19, which gathered over 600,000 petition signatures calling for a national cancer recovery plan. Source ↗
- Co-edits 'Treatment of Cancer' (7th edition, CRC Press/Routledge), the standard UK oncology textbook, with over 300 research publications and an H-factor of 63. Source ↗
- Established the first Ralston Paterson Chair in Radiation Oncology at the Christie Hospital and set up the Wolfson Molecular Imaging Centre at the University of Manchester in 2000. Source ↗
- Returned to Imperial College London in 2010 as Visiting Professor in Oncology, leading large-scale international research programmes in PET imaging and laser-based ion therapy for cancer. Source ↗
What Pat Price has said
“Thousands of cancer patients risk dying prematurely either because they are not getting radiotherapy at all or because of huge delays in starting radiation treatment.”
leading oncologist and chair of Radiotherapy UK · Hospital discharge / bed-blocking · 27 Aug 2026 · More than 60,000 cancer patients in England ‘not getting necessary radiotherapy’ ↗
“The big tragedy of the UK's poor cancer survival rates is that we know how to fix them but bureaucracy and broken funding systems keep us from making progress. Cutting-edge cancer treatments in radiotherapy, such as SABR and SGRT, allow for more cancer cures, more precise treatments that reduce side effects and cut down waiting lists.”
Chair of Radiotherapy UK and visiting professor of oncology at Imperial College London · Hospital discharge / bed-blocking · 27 Aug 2026 · ‘Deadly postcode lottery’ restricting new cancer treatments in England, doctors say ↗
Where Pat Price has been quoted
- 'My cancer spread while I waited 128 days for an op': The cost of England's care gapbbc.co.uk · 29 Sept 2026
- More than 60,000 cancer patients in England ‘not getting necessary radiotherapy’theguardian.com · 27 Aug 2026
- ‘Deadly postcode lottery’ restricting new cancer treatments in England, doctors saytheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Contact & links
- Staff pagehttps://radiotherapy.org.uk/about-us-old/our-people/
- Websitehttps://patprice.co.uk/about/
- LinkedInhttps://www.linkedin.com/in/pat-price-b4281682/
- Press office emailinfo@radiotherapy.org.ukpublished here ↗
- Press office phone02030515671published here ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.